Foresight Diagnostics Unveils CLARITY™ MRD Assay Data at Major Hematology Conferences Foresight Diagnostics is set to present innovative data on its CLARITY™ MRD assay at the 2025 EHA Congress and ICML, showcasing new advancements in lymphoma treatment.

Foresight Diagnostics Unveils CLARITY™ MRD Assay Data at Major Hematology Conferences #United_States #Hematology #Boulder #Foresight_Diagnostics #CLARITY_MRD

Foresight Diagnostics Shares Validated Data on MRD Assay at ASCO 2025 Foresight Diagnostics announces independent validation of its CLARITY MRD assay in frontline DLBCL patients, showcasing significant prognostic insights at the 2025 ASCO Annual Meeting.

Foresight Diagnostics Shares Validated Data on MRD Assay at ASCO 2025 #United_States #Chicago #DLBCL #Foresight_Diagnostics #CLARITY_MRD